QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir

NCT04515797 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Unable to meet enrollment goal prior to drug expiration

Conditions

Kidney Failure
Hepatitis C
Kidney Disease, Chronic

Interventions

DRUG: Glecaprevir and Pibrentasvir

Sponsor

Massachusetts General Hospital